ZBTB42

gene
On this page

Also known as ZNF925

Summary

ZBTB42 (zinc finger and BTB domain containing 42, HGNC:32550) is a protein-coding gene on chromosome 14q32.33, encoding Zinc finger and BTB domain-containing protein 42 (B2RXF5). Transcriptional repressor.

The protein encoded by this gene is a member of the C2H2 zinc finger protein family. This protein is predicted to have a pox virus and zinc finger (POZ) domain at the N-terminus and four zinc finger domains at the C-terminus. In human and mouse, the protein localizes to the nuclei of skeletal muscle cells. Knockdown of this gene in zebrafish results in abnormal skeletal muscle development and myofibrillar disorganization. A novel homozygous variant of the human gene has been associated with lethal congenital contracture syndrome, an autosomal recessive disorder that results in muscle wasting.

Source: NCBI Gene 100128927 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): lethal congenital contracture syndrome 6 (Moderate, GenCC)
  • GWAS associations: 10
  • Clinical variants (ClinVar): 77 total — 1 pathogenic
  • Phenotypes (HPO): 8
  • MANE Select transcript: NM_001137601

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:32550
Approved symbolZBTB42
Namezinc finger and BTB domain containing 42
Location14q32.33
Locus typegene with protein product
StatusApproved
AliasesZNF925
Ensembl geneENSG00000179627
Ensembl biotypeprotein_coding
OMIM613915
Entrez100128927

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000342537, ENST00000555360, ENST00000962340

RefSeq mRNA: 2 — MANE Select: NM_001137601 NM_001137601, NM_001370342

CCDS: CCDS45174

Canonical transcript exons

ENST00000342537 — 1 exons

ExonStartEnd
ENSE00001213415104801101104804712

Expression profiles

Bgee: expression breadth ubiquitous, 163 present calls, max score 83.87.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.9119 / max 49.2911, expressed in 1038 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1418422.26051022
1418430.6514111

Top tissues by expression

246 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
parotid glandUBERON:000183183.87silver quality
esophagus squamous epitheliumUBERON:000692081.18gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099180.37gold quality
apex of heartUBERON:000209878.66gold quality
body of pancreasUBERON:000115078.15gold quality
olfactory segment of nasal mucosaUBERON:000538677.48gold quality
palpebral conjunctivaUBERON:000181277.17gold quality
gastrocnemiusUBERON:000138876.76gold quality
body of stomachUBERON:000116175.86gold quality
muscle of legUBERON:000138375.31gold quality
epithelial cell of pancreasCL:000008375.30gold quality
pancreasUBERON:000126474.67gold quality
amniotic fluidUBERON:000017373.44gold quality
nasal cavity mucosaUBERON:000182673.40gold quality
saliva-secreting glandUBERON:000104473.39gold quality
stomachUBERON:000094573.14gold quality
gingival epitheliumUBERON:000194973.14gold quality
ventricular zoneUBERON:000305372.92gold quality
heart left ventricleUBERON:000208472.85gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047372.82gold quality
esophagus mucosaUBERON:000246972.67gold quality
upper arm skinUBERON:000426372.57gold quality
minor salivary glandUBERON:000183072.50gold quality
cardiac ventricleUBERON:000208272.46gold quality
right lobe of thyroid glandUBERON:000111972.15gold quality
lower lobe of lungUBERON:000894972.10silver quality
hindlimb stylopod muscleUBERON:000425272.04gold quality
right lobe of liverUBERON:000111472.00gold quality
mouth mucosaUBERON:000372971.65gold quality
mucosa of transverse colonUBERON:000499171.64gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes7.46
E-CURD-89no79.82

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

57 targeting ZBTB42, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-8485100.0077.574731
HSA-MIR-4692100.0067.322066
HSA-MIR-223-3P99.9970.141140
HSA-MIR-366299.9973.825684
HSA-MIR-451499.9967.101870
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-444799.8567.812900
HSA-MIR-6817-3P99.7968.352126
HSA-MIR-3156-3P99.7666.72939
HSA-MIR-6764-5P99.7567.892304
HSA-MIR-182599.7268.111089
HSA-MIR-29899.6367.561916
HSA-MIR-613499.6365.681537
HSA-MIR-1260A99.6166.671098
HSA-MIR-1260B99.6166.671098
HSA-MIR-613299.6065.831554
HSA-MIR-6836-5P99.6065.621538
HSA-MIR-3136-3P99.5766.59781
HSA-MIR-7155-3P99.5766.48794
HSA-MIR-447299.5666.081478
HSA-MIR-199A-5P99.5169.711107
HSA-MIR-199B-5P99.5169.741098
HSA-MIR-1213299.4768.901341
HSA-MIR-94099.3766.142064
HSA-MIR-532-3P99.3465.761195
HSA-MIR-6808-5P99.3166.232150
HSA-MIR-6893-5P99.3166.252119

Literature-anchored findings (GeneRIF, showing 2)

  • Data show that ZBTB42 protein is expressed in human skeletal muscle and a murine cell line C2C12 myotubes. (PMID:21193930)
  • ZBTB42 mutation defines a novel lethal congenital contracture syndrome. (PMID:25055871)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriosi:dkey-79d12.4ENSDARG00000078018
mus_musculusZbtb42ENSMUSG00000037638
rattus_norvegicusZbtb42ENSRNOG00000037562

Paralogs (36): ZBTB32 (ENSG00000011590), SNAI2 (ENSG00000019549), PRDM1 (ENSG00000057657), PRDM6 (ENSG00000061455), ZNF76 (ENSG00000065029), PATZ1 (ENSG00000100105), MAZ (ENSG00000103495), ZBTB16 (ENSG00000109906), ZNF451 (ENSG00000112200), ZBTB45 (ENSG00000119574), ZNF410 (ENSG00000119725), SNAI1 (ENSG00000124216), ZNF384 (ENSG00000126746), ZBTB1 (ENSG00000126804), VEZF1 (ENSG00000136451), PRDM14 (ENSG00000147596), ZNF276 (ENSG00000158805), ZNF362 (ENSG00000160094), ZNF653 (ENSG00000161914), ZNF281 (ENSG00000162702), ZNF148 (ENSG00000163848), ZNF143 (ENSG00000166478), HIC2 (ENSG00000169635), PRDM10 (ENSG00000170325), ZNF296 (ENSG00000170684), ZNF692 (ENSG00000171163), ZNF575 (ENSG00000176472), HIC1 (ENSG00000177374), ZBTB18 (ENSG00000179456), ZBTB20 (ENSG00000181722), ZBTB7C (ENSG00000184828), SNAI3 (ENSG00000185669), ZFP91 (ENSG00000186660), MTF1 (ENSG00000188786), SCRT2 (ENSG00000215397), SCRT1 (ENSG00000261678)

Protein

Protein identifiers

Zinc finger and BTB domain-containing protein 42B2RXF5 (reviewed: B2RXF5)

All UniProt accessions (1): B2RXF5

UniProt curated annotations — full annotation on UniProt →

Function. Transcriptional repressor. Specifically binds DNA and probably acts by recruiting chromatin remodeling multiprotein complexes.

Subcellular location. Cytoplasm. Nucleus. Nucleoplasm.

Tissue specificity. Expressed in skeletal muscle (at protein level).

Disease relevance. Lethal congenital contracture syndrome 6 (LCCS6) [MIM:616248] A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy and congenital non-progressive joint contractures. The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS6 features include severe polyhydramnios and absent stomach, in addition to multiple contracture deformities. The disease is caused by variants affecting the gene represented in this entry.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family. ZBTB18 subfamily.

RefSeq proteins (2): NP_001131073, NP_001357271 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000210BTB/POZ_domDomain
IPR011333SKP1/BTB/POZ_sfHomologous_superfamily
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF00651, PF13894

UniProt features (12 total): zinc finger region 4, region of interest 3, chain 1, domain 1, sequence variant 1, sequence conflict 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-B2RXF5-F150.030.00

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 87 (showing top): GOBP_MUSCLE_STRUCTURE_DEVELOPMENT, BILD_E2F3_ONCOGENIC_SIGNATURE, chr14q32, CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP, GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR8485, MIR223_3P, GSE11924_TFH_VS_TH2_CD4_TCELL_UP, MIR571, GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP

GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357), muscle organ development (GO:0007517)

GO Molecular Function (5): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (4): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), plasma membrane (GO:0005886)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of transcription by RNA polymerase II2
transcription by RNA polymerase II2
cellular anatomical structure2
negative regulation of DNA-templated transcription1
regulation of DNA-templated transcription1
animal organ development1
muscle structure development1
chromatin1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
DNA-binding transcription factor activity1
nucleic acid binding1
transition metal ion binding1
binding1
cation binding1
intracellular membrane-bounded organelle1
nuclear lumen1
intracellular anatomical structure1
membrane1
cell periphery1

Protein interactions and networks

STRING

374 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZBTB42UTP25Q68CQ4479
ZBTB42TRERF1Q96PN7449
ZBTB42SLC26A1Q9H2B4419
ZBTB42ZG16BQ96DA0419
ZBTB42GNA15P30679415
ZBTB42CHST2Q9Y4C5384
ZBTB42AKT1P31749376
ZBTB42ANKEF1Q9NU02370
ZBTB42GTPBP10A4D1E9321
ZBTB42S100PBPQ96BU1310
ZBTB42PGBD1Q96JS3309
ZBTB42SULF2Q8IWU5305
ZBTB42GRHL1Q9NZI5293
ZBTB42SPDEFO95238292
ZBTB42SCGB3A1Q96QR1284

IntAct

161 interactions, top by confidence:

ABTypeScore
ZBTB42MDFIpsi-mi:“MI:0915”(physical association)0.560
ZBTB42KRT40psi-mi:“MI:0915”(physical association)0.560
ZBTB42GOLGA2psi-mi:“MI:0915”(physical association)0.560
ZBTB42ZBTB7Bpsi-mi:“MI:0915”(physical association)0.560
ZBTB42MID2psi-mi:“MI:0915”(physical association)0.560
ZBTB42NCK2psi-mi:“MI:0915”(physical association)0.560
ZBTB42POLR1Cpsi-mi:“MI:0915”(physical association)0.560
ZBTB42CIDECpsi-mi:“MI:0915”(physical association)0.560
ZBTB42RAD51Dpsi-mi:“MI:0915”(physical association)0.560
ZBTB42AIRIMpsi-mi:“MI:0915”(physical association)0.560
ZBTB42TTC23psi-mi:“MI:0915”(physical association)0.560
ZBTB42ZNF330psi-mi:“MI:0915”(physical association)0.560
ZBTB42USHBP1psi-mi:“MI:0915”(physical association)0.560
ZBTB42KCTD9psi-mi:“MI:0915”(physical association)0.560
ZBTB42NDOR1psi-mi:“MI:0915”(physical association)0.560
ZBTB42CTBP2psi-mi:“MI:0915”(physical association)0.560
ZBTB42BLKpsi-mi:“MI:0915”(physical association)0.560
ZBTB42MAGOHBpsi-mi:“MI:0915”(physical association)0.560
ZBTB42OTX1psi-mi:“MI:0915”(physical association)0.560
ZBTB42OAZ3psi-mi:“MI:0915”(physical association)0.560
ZBTB42psi-mi:“MI:0915”(physical association)0.560
ZBTB42NOC4Lpsi-mi:“MI:0915”(physical association)0.560
ZBTB42FMR1psi-mi:“MI:0915”(physical association)0.560
ZBTB42CCDC102Bpsi-mi:“MI:0915”(physical association)0.560
ZBTB42GUCD1psi-mi:“MI:0915”(physical association)0.560
ZBTB42CINPpsi-mi:“MI:0915”(physical association)0.560
ZBTB42ZBTB16psi-mi:“MI:0915”(physical association)0.560
ZBTB42GEMpsi-mi:“MI:0915”(physical association)0.560
ZBTB42KANK2psi-mi:“MI:0915”(physical association)0.560
ZBTB42UBASH3Apsi-mi:“MI:0915”(physical association)0.560

BioGRID (78): ZBTB42 (Affinity Capture-MS), PRMT9 (Affinity Capture-MS), FBXL17 (Affinity Capture-MS), VRK1 (Affinity Capture-MS), RNF187 (Affinity Capture-MS), MID1 (Affinity Capture-MS), ZNF516 (Affinity Capture-MS), CTBP2 (Affinity Capture-MS), ZPR1 (Affinity Capture-MS), GGPS1 (Affinity Capture-MS), ZBTB42 (PCA), ZBTB42 (Affinity Capture-RNA), ZBTB42 (Two-hybrid), ZBTB42 (Two-hybrid), ZBTB42 (Two-hybrid)

ESM2 similar proteins: A0JNJ4, A2APT9, A6NEL2, A6NP61, B1ASB6, B1WBS3, B2RXF5, F6WEQ6, O15015, O43918, O88282, O88286, O95785, P98168, P98169, Q2M3G4, Q2MHN3, Q2QGD7, Q3U1J1, Q3U381, Q497V6, Q5SW24, Q5SXM2, Q6YND2, Q6ZMQ8, Q6ZMY3, Q7TN08, Q7TSX9, Q80SU3, Q80YE4, Q811H0, Q8BG26, Q8BZW2, Q8C8V1, Q8IX07, Q8IY92, Q8N143, Q8N1G0, Q8NC74, Q8TBE0

Diamond homologs: A0JN76, A1L2U9, A1YEX3, A1YPR0, A2AAX3, B1WAZ8, B1WBS3, B1WBU4, B2RXF5, D3ZA50, O14867, O15062, O15156, O15209, O43167, O43298, O43829, O88282, O88939, O93567, O95365, P24278, P41182, P41183, P52739, P97302, P97303, Q08376, Q0IH98, Q0IJ29, Q0P4X6, Q0VCJ6, Q13105, Q14526, Q1H9T6, Q1L8W0, Q2T9Z7, Q3B725, Q3B7N9, Q3SWU4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

77 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance62
Likely benign5
Benign8

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
815682GRCh37/hg19 14q32.33(chr14:104764078-107285437)x1Pathogenic

SpliceAI

192 predictions. Top by Δscore:

VariantEffectΔscore
14:104800701:GT:Gdonor_loss0.9900
14:104800702:T:Gdonor_loss0.9900
14:104800701:G:GGdonor_gain0.9700
14:104801255:C:Gdonor_gain0.9700
14:104800698:G:GTdonor_gain0.9600
14:104800698:GAG:Gdonor_gain0.9600
14:104800697:GGAG:Gdonor_gain0.9500
14:104801175:GCCCA:Gacceptor_loss0.9500
14:104801176:CCCA:Cacceptor_loss0.9500
14:104801177:CCA:Cacceptor_loss0.9500
14:104801178:CAGG:Cacceptor_loss0.9500
14:104801179:A:ATacceptor_loss0.9500
14:104801072:G:GTdonor_gain0.9300
14:104801072:G:Tdonor_gain0.9300
14:104801179:A:AGacceptor_gain0.9200
14:104801180:G:GGacceptor_gain0.9200
14:104801046:C:Tdonor_gain0.8800
14:104801180:GGT:Gacceptor_gain0.8800
14:104801172:T:Aacceptor_loss0.8700
14:104801357:A:AGacceptor_gain0.8700
14:104801358:G:GGacceptor_gain0.8700
14:104801357:AG:Aacceptor_gain0.8500
14:104801358:GG:Gacceptor_gain0.8500
14:104800909:G:GTdonor_gain0.8400
14:104800679:A:Tdonor_gain0.8200
14:104801355:ACAG:Aacceptor_gain0.8200
14:104801008:C:Gdonor_gain0.8000
14:104801076:T:TAdonor_gain0.8000
14:104800703:GAGC:Gdonor_loss0.7700
14:104800923:G:GTdonor_gain0.7500

AlphaMissense

2707 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:104802308:T:CF371L1.000
14:104802309:T:CF371S1.000
14:104802310:T:AF371L1.000
14:104802310:T:GF371L1.000
14:104802392:T:CF399L1.000
14:104802394:C:AF399L1.000
14:104802394:C:GF399L1.000
14:104802224:T:CF343L0.999
14:104802226:C:AF343L0.999
14:104802226:C:GF343L0.999
14:104802251:C:GH352D0.999
14:104802287:T:CC364R0.999
14:104802296:T:CC367R0.999
14:104802309:T:GF371C0.999
14:104802371:T:CC392R0.999
14:104802393:T:CF399S0.999
14:104802203:T:CC336R0.998
14:104802225:T:CF343S0.998
14:104802289:T:GC364W0.998
14:104802296:T:AC367S0.998
14:104802297:G:CC367S0.998
14:104802308:T:AF371I0.998
14:104802327:T:CL377P0.998
14:104802335:C:GH380D0.998
14:104802337:C:AH380Q0.998
14:104802337:C:GH380Q0.998
14:104802373:C:GC392W0.998
14:104802382:T:GC395W0.998
14:104802083:T:CC296R0.997
14:104802205:C:GC336W0.997

dbSNP variants (sampled 300 via entrez): RS1000065107 (14:104802696 C>A,T), RS1000442977 (14:104801677 C>A,G), RS1000699304 (14:104804368 C>T), RS1000731457 (14:104804598 G>A,T), RS1000896190 (14:104798813 C>T), RS1001199482 (14:104798653 C>G,T), RS1001717649 (14:104800601 C>G,T), RS1001845566 (14:104804446 T>C), RS1002033436 (14:104799359 A>AC), RS1002189007 (14:104804269 C>G,T), RS1002448034 (14:104799622 G>A), RS1003157437 (14:104802915 A>T), RS1003188776 (14:104803238 C>G,T), RS1003894309 (14:104804909 A>T), RS1003994434 (14:104799877 T>C)

Disease associations

OMIM: gene MIM:613915 | disease phenotypes: MIM:616248

GenCC curated gene-disease

DiseaseClassificationInheritance
lethal congenital contracture syndrome 6ModerateAutosomal recessive

Mondo (1): lethal congenital contracture syndrome 6 (MONDO:0014549)

Orphanet (0):

HPO phenotypes

8 total (8 of 8 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0000256Macrocephaly
HP:0001558Decreased fetal movement
HP:0001561Polyhydramnios
HP:0002803Congenital contracture
HP:0002804Arthrogryposis multiplex congenita
HP:0010963Absence of stomach bubble on fetal sonography
HP:0030674Antenatal onset

GWAS associations

10 associations (top):

StudyTraitp-value
GCST002223_64HDL cholesterol1.000000e-08
GCST002899_22HDL cholesterol8.000000e-09
GCST004232_77HDL cholesterol levels3.000000e-08
GCST008070_33HDL cholesterol levels2.000000e-09
GCST008075_103HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)3.000000e-19
GCST008075_47HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)7.000000e-14
GCST008084_16HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)1.000000e-13
GCST008084_228HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)3.000000e-20
GCST008085_162HDL cholesterol levels in current drinkers6.000000e-09
GCST008085_25HDL cholesterol levels in current drinkers2.000000e-12

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004612high density lipoprotein cholesterol measurement
EFO:0004329alcohol drinking

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB variants

1 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs3803300AKT1, ZBTB4230.251risperidone

CTD chemical–gene interactions

25 total (human), top 25 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cisplatinaffects cotreatment, increases expression, decreases expression2
aristolochic acid Idecreases expression1
GSK-J4decreases expression1
FR900359increases phosphorylation1
hydroxyhydroquinonedecreases expression, decreases reaction1
zinc chromatedecreases expression, increases abundance1
ferrous chloridedecreases expression1
4-aminobenzhydrazidedecreases expression, decreases reaction1
S-(1,2-dichlorovinyl)cysteineaffects response to substance, increases expression1
di-n-butylphosphoric acidaffects expression1
chromium hexavalent iondecreases expression, increases abundance1
abrinedecreases expression1
jinfukangaffects cotreatment, increases expression1
Temozolomideincreases expression1
Arsenic Trioxideincreases expression1
Benzo(a)pyreneaffects methylation1
Benztropineaffects cotreatment, decreases expression1
Cuprizoneaffects cotreatment, decreases expression1
Lipopolysaccharidesaffects response to substance, increases expression1
Smokedecreases expression1
Thiramdecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Urethanedecreases expression1
Valproic Acidincreases methylation1
1-Methyl-4-phenylpyridiniumincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.